BioInvent International AB announced the appointment of the Alexander Eggermont MD, PhD, as a member of its scientific advisory board. Prof. Eggermont is an internationally recognized expert in surgical oncology, immunotherapy, melanoma, sarcoma and cancer drug development. He currently holds roles as Chief Scientific Officer at the Princess M?xima Center for Pediatric Oncology and Professor of Clinical & Translational Immunotherapy at the University Medical Center Utrecht, the Netherlands. In Germany he is Coordinator at the Comprehensive Cancer Center Program for Deutsche KrebsHilfe and Strategic Advisor at the German Cancer Research Institute (DKFZ), Heidelberg.